The EU-India agreement might not stop generic drug seizures at European portsJust a few months ago, Indian officials were up in arms against the European Union (EU) after several generic drug consignments en route to Latin America and Africa had been seized by EU customs.

Civil Society Groups Urge End To India Project, Allege Nexus With MNC Pharma Companies

TK ARUN

GERMAN drugmaker Bayer has filed a patent infringement case against Cipla, the largest domestic drugseller, to stop the Mumbaibased company from selling its generic version of Bayer

THE Delhi High Court has turned down a plea by US pharma major Bristol-Myers Squibb (BMS) to ban India

New Delhi: The US Food and Drug Administration (FDA) has ordered domestic company, Glenmark Generics to stop marketing

RANBAXY Laboratories on Monday announced it has settled a patent dispute with Takeda Pharmaceutical allowing the Gurgaon-based drugmaker to launch its generic tablets of Takeda

Ahmedabad: Leading UK drugmaker AstraZeneca Plc will brand and market 18 medicines manufactured by the Rs 1,600-crore Ahmedabad-based pharma company Torrent Pharmaceuticals in 9 emerging economies.

Chennai: Nearly $60 billion worth of patents for drugs is set to expire in the next four years across the world and Indian pharmaceutical companies are now in a position to take a major share of this pie, industry members said.

THE financial meltdown may be history, but its effects continue to haunt, especially when it comes to corporate innovations. A case in point is the dip in the number of patent filings in India in 2009-10.